Permission to use the third vaccination from COVID-19 may be issued in the near future.
The US Food and Drug Administration (FDA) on Wednesday, September 22, approved the use of booster vaccinations using Pfizer/BioNTech vaccines to combat COVID-19.
An additional third vaccination is recommended for people aged 65 years and older, as well as people aged 18-64 years who may face serious complications with COVID-19 disease (we are talking about people with chronic diseases and people whose professional activity increases their risk of infection).
For boosters to be used in the United States, an appropriate decision of the Centers for Disease Control and Prevention (CDC) is necessary. The CDC may make this decision on Thursday, September 23.
Previously, the use of a booster was recommended by the board of experts at the FDA.
Some states, including Israel and the United Kingdom, are already conducting booster vaccination campaigns. In the United States, such vaccinations are given to people suffering from immune disorders – about 2 million people have received them.
Also, on September 22, the Brazilian medical regulator Anvisa said that the death of a 16-year-old teenager who received the first dose of the vaccine Pfizer/BioNTech is not associated with vaccination – its cause is called an autoimmune disease. About 3.5 million Brazilians aged 12-17 years received similar vaccinations.